
About Arihant Medicines Private Limited
Data last updated:
Arihant Medicines Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 March 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2004PTC145129. Its GSTIN is 27AAECA6447J1ZG (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Prashant Gupta (Managing Director) and Gayatri Prashant Gupta.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 222 Atlanta Estatedr Ambedkar Chowk Off W Exp Highway Goregaon (E), Mumbai, Maharashtra, India – 400063.
As per the financials filed for FY 2024, the company reported a revenue of ₹31.36 Lakh, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹5.9 Lakh (net margin 18.8%) and EBITDA of ₹6.74 Lakh (EBITDA margin 21.5%). Revenue has declined at a compounded annual rate (CAGR) of 10% over three years and 3% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website arihantmedicines.com.
Company details
Contact details
Arihant Medicines Private Limited's registered office is in Mumbai, Maharashtra. Its website is arihantmedicines.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address222 Atlanta Estatedr Ambedkar Chowk Off W Exp Highway Goregaon (E), Mumbai, Maharashtra, India – 400063
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Arihant Medicines Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Arihant Medicines is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Arihant Medicines Private Limited, buy the company report.
Financials of Arihant Medicines Private Limited
FY 2024 filings availableArihant Medicines Private Limited reported revenue of ₹31.36 Lakh (up 10% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 10% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 3%. EBITDA rose 339% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.74 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.9 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 21.5% | ||||
| Net Profit Margin | 18.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Arihant Medicines Private Limited, buy the company report.
Board of directors of Arihant Medicines Private Limited
Arihant Medicines has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prashant Gupta | Managing Director | 17 Mar 2007 | 19 Years 8 Months | Current |
| Gayatri Prashant Gupta | Director | 17 Mar 2007 | 19 Years 8 Months | Current |
Peer comparison
Arihant Medicines Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pad Pharma Private Limited | ₹31.65 Lakh (FY 2025) | -4.0% | Kashipur, Uttarakhand, India | |||
| Zovalta Pharmaceuticals Private Limited | ₹31.6 Lakh (FY 2021) | -27.0% | Hyderabad, Telangana, India | |||
| Arihant Medicines Private Limitedthis company | ₹31.36 Lakh (FY 2024) | ₹5.9 Lakh | 18.8% | 10.0% | Mumbai, Maharashtra, India | |
| Bemaxx Pharmaceuticals Private Limited | ₹31.34 Lakh (FY 2024) | 12.0% | Chennai, Tamil Nadu, India | |||
| Nuera Pharmaceuticals Private Limited | ₹31.23 Lakh (FY 2025) | 73.0% | Bhopal, Madhya Pradesh, India |
To see the full peer comparison of Arihant Medicines Private Limited, buy the company report.
Auditor
Arihant Medicines Private Limited is audited by RAHUL PRAMOD & CO for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAHUL PRAMOD & CO | FY 2018 | 100149W |
Shareholding
The shareholding of Arihant Medicines Private Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Arihant Medicines Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Arihant Medicines Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Arihant Medicines Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Arihant Medicines has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECA6447J1ZG | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Arihant Medicines Private Limited, buy the company report.
Recent activity
Arihant Medicines Private Limited has 2 board changes on record since 2007: 2 appointments. The latest: Gayatri Prashant Gupta was appointed as Director on 17 Mar 2007.
Frequently asked questions
Arihant Medicines is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 March 2004 (22+ years old) and is registered under CIN U24230MH2004PTC145129.
Arihant Medicines has 2 current directors:
- Prashant Gupta - Managing Director
- Gayatri Prashant Gupta - Director
The latest financial statements of Arihant Medicines on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Arihant Medicines is 27AAECA6447J1ZG, registered in Maharashtra.
The CIN (Corporate Identification Number) of Arihant Medicines is U24230MH2004PTC145129. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Arihant Medicines was incorporated on 17 March 2004, making it 22+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Arihant Medicines by revenue are Pad Pharma Private Limited, Zovalta Pharmaceuticals Private Limited, Bemaxx Pharmaceuticals Private Limited, Nuera Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Gayatri Prashant Gupta was appointed as Director on 17 Mar 2007. Prashant Gupta was appointed as Managing Director on 17 Mar 2007.
Arihant Medicines can be reached through the website arihantmedicines.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Arihant Medicines is at 222 Atlanta Estatedr Ambedkar Chowk Off W Exp Highway Goregaon E, Mumbai, Maharashtra, India – 400063.
Arihant Medicines operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

